Deciphering the role of QPCTL in glioma progression and cancer immunotherapy

Background Glioma is the most lethal and most aggressive brain cancer, and currently there is no effective treatment. Cancer immunotherapy is an advanced therapy by manipulating immune cells to attack cancer cells and it has been studied a lot in glioma treatment. Targeting the immune checkpoint CD47 or blocking the CD47-SIRPα axis can effectively eliminate glioma cancer cells but also brings side effects such as anemia. Glutaminyl-peptide cyclotransferase-like protein (QPCTL) catalyzes the pyroglutamylation of CD47 and is crucial for the binding between CD47 and SIRPα. Further study found that loss of intracellular QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunity. However, the role of QPCTL in glioma and the relationship between its expression and clinical outcomes remains unclear. Deciphering the role of QPCTL in glioma will provide a promising therapy for glioma cancer immunotherapy. Methods QPCTL expression in glioma tissues and normal adjacent tissues was primarily analyzed in The Cancer Genome Atlas (TCGA) database, and further validated in another independent cohort from the Gene Expression Omnibus (GEO) database, Chinese Glioma Genome Atlas (CGGA), and Human Protein Atlas (HPA). The relationships between QPCTL expression and clinicopathologic parameters and overall survival (OS) were assessed using multivariate methods and Kaplan-Meier survival curves. And the proteins network with which QPCTL interacted was built using the online STRING website. Meanwhile, we use Tumor Immune Estimation Resource (TIMER) and Gene Expression Profiling Interactive Analysis (GEPIA) databases to investigate the relationships between QPCTL expression and infiltrated immune cells and their corresponding gene marker sets. We analyzed the Differentially Expressed Genes (DEGs) including GO/KEGG and Gene Set Enrichment Analysis (GSEA) based on QPCTL-high and -low expression tumors. Results In contrast to normal tissue, QPCTL expression was higher in glioma tumor tissue (p < 0.05). Higher QPCTL expression was closely associated with high-grade malignancy and advanced tumor stage. Univariate and multivariate analysis indicated the overall survival of glioma patients with higher QPCTL expression is shorter than those with lower QPCTL expression (p < 0.05). Glioma with QPCTL deficiency presented the paucity of infiltrated immune cells and their matching marker sets. Moreover, QPCTL is essential for glioma cell proliferation and tumor growth and is a positive correlation with glioma cell stemness. Conclusion High QPCTL expression predicts high grades of gliomas and poor prognosis with impaired infiltration of adaptive immune cells in the tumor microenvironment as well as higher cancer stemness. Moreover, targeting QPCTL will be a promising immunotherapy in glioma cancer treatment.

[1]  Yufeng Shi,et al.  Functions of glutaminyl cyclase and its isoform in diseases , 2023, Visualized Cancer Medicine.

[2]  Taiwen Li,et al.  TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment , 2022, Nucleic Acids Res..

[3]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018. , 2022, Neuro-oncology.

[4]  R. Burger,et al.  Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab , 2022, Frontiers in Immunology.

[5]  Y. Liu,et al.  Intracavity generation of glioma stem cell–specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy , 2022, Science Translational Medicine.

[6]  Wei Wu,et al.  Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy , 2022, Theranostics.

[7]  M. Schrappe,et al.  Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL. , 2022, Blood.

[8]  Aijun Wang,et al.  Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion , 2022, Nature Communications.

[9]  T. Schumacher,et al.  QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment , 2022, Oncoimmunology.

[10]  Qing Li,et al.  Uncovering the Immune Cell Infiltration Landscape in Low-Grade Glioma for Aiding Immunotherapy , 2022, Journal of oncology.

[11]  Betty Y. S. Kim,et al.  Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target , 2022, Nature communications.

[12]  Mariella G. Filbin,et al.  GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas , 2022, Nature.

[13]  J. Wargo,et al.  Mechanisms of immune activation and regulation: lessons from melanoma , 2022, Nature Reviews Cancer.

[14]  S. Rutz,et al.  Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunity , 2022, Nature Immunology.

[15]  J. Serody,et al.  B Cell Function in the Tumor Microenvironment , 2022, Annual Review of Immunology.

[16]  C. Brennan,et al.  Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy. , 2022, Developmental cell.

[17]  R. Appay,et al.  [The 2021 WHO classification of tumours of the central nervous system]. , 2021, Annales de pathologie.

[18]  M. Hadamitzky,et al.  Glioma: molecular signature and crossroads with tumor microenvironment , 2021, Cancer and Metastasis Reviews.

[19]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018. , 2021, Neuro-oncology.

[20]  Susan M. Chang,et al.  Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement. , 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  Guohua Yang,et al.  Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis , 2021, Cancer management and research.

[22]  Changming Tan,et al.  Research status and the prospect of POSTN in various tumors. , 2021, Neoplasma.

[23]  L. Qu,et al.  QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis , 2021, International journal of oncology.

[24]  P. Scheltens,et al.  Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD—VIVIAD , 2021, Alzheimer's Research & Therapy.

[25]  Anxun Wang,et al.  Arecoline induces epithelial‐mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression , 2021, Cancer science.

[26]  Alyssa R. Richman,et al.  Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis , 2021, Cell.

[27]  N. Kanemitsu,et al.  Chronic treatment with the (iso-)glutaminyl cyclase inhibitor PQ529 is a novel and effective approach for glomerulonephritis in chronic kidney disease , 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.

[28]  E. Kenigsberg,et al.  Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease , 2020, Cell.

[29]  M. Lleonart,et al.  Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies , 2020, Frontiers in Oncology.

[30]  J. Kros,et al.  Periostin Is Expressed by Pericytes and Is Crucial for Angiogenesis in Glioma. , 2020, Journal of neuropathology and experimental neurology.

[31]  Blaine R. Roberts,et al.  Increased glutaminyl cyclase activity in brains of Alzheimer’s disease individuals , 2020, Journal of neurochemistry.

[32]  Jie Dong,et al.  Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma , 2020, Frontiers in Immunology.

[33]  T. Takayama,et al.  Cancer‐associated adipocytes promote pancreatic cancer progression through SAA1 expression , 2020, Cancer science.

[34]  X. Liu,et al.  Large-scale public data reuse to model immunotherapy response and resistance , 2020, Genome Medicine.

[35]  Z. Wang,et al.  Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data for Chinese Glioma Patients , 2020, bioRxiv.

[36]  A. Faried,et al.  Identification of Periostin as a Potential Biomarker in Gliomas by Database Mining. , 2019, World neurosurgery.

[37]  I. Weissman,et al.  Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma , 2019, Innate immunity.

[38]  H. Tian,et al.  Identification of Glutaminyl Cyclase isoenzyme isoQC as a regulator of SIRPα-CD47 axis , 2019, Cell Research.

[39]  T. Schumacher,et al.  Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and target for cancer immunotherapy , 2019, Nature Medicine.

[40]  I. Weissman,et al.  Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma , 2019, Proceedings of the National Academy of Sciences.

[41]  X. Liu,et al.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.

[42]  Edward F. Chang,et al.  Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. , 2017, Cancer cell.

[43]  Theresa A. Storm,et al.  Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors , 2017, Science Translational Medicine.

[44]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[45]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[46]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[47]  P. Quax,et al.  The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions , 2011, EMBO molecular medicine.

[48]  A. Kehlen,et al.  Isolation of an isoenzyme of human glutaminyl cyclase: retention in the Golgi complex suggests involvement in the protein maturation machinery. , 2008, Journal of molecular biology.